Evidence map›Paper›PMID 29200867›Full record

ArticleOncoTargets and therapy2017

The relationship between

Hao Qiu, Yafeng Wang, Mingqiang Kang, Hao Ding, Chao Liu, Weifeng Tang, Zhenzhou Xiao, Yu Chen

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Genetic variants ofInternational journal of medical sciences · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Investigation ofBioscience reports · 2019
    Article
  8. Relationship betweenCancer management and research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Hao Qiu *Department of Immunology, School of Medicine, Jiangsu University, Zhenjiang.
Yafeng Wang *Department of Cardiology, People's Hospital of Xishuangbanna Dai Autonomous Prefecture, Jinghong.
Mingqiang Kang *Department of Thoracic Surgery, Fujian Medical University Union Hospital.
Hao DingDepartment of Respiratory Disease.
Chao LiuDepartment of Cardiothoracic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang.
Weifeng TangDepartment of Cardiothoracic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang.
Zhenzhou XiaoDepartment of Clinical Laboratory.
Yu ChenCancer Bio-immunotherapy Center.
Jiangsu University · CNAffiliated Hospital of Jiangsu University · CNFujian Medical University · CNFujian Provincial Cancer Hospital · CNInstitute of Clinical Research · USJingning County People's Hospital · CNState Key Laboratory of Respiratory Disease · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this case-control study was to assess whether

Indexed as

ESCCIGF2BP2polymorphismPPARGrisk

Identifiers

PMID29200867
PMCPMC5702164
OpenAlexW2769939168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.